PDT Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-41,693
| Closed | -$380K | – | 708 |
|
|
2025
Q2 | $380K | Sell |
41,693
-74,835
| -64% | -$550K | 0.02% | 559 |
|
|
2025
Q1 | $926K | Sell |
116,528
-118,569
| -50% | -$868K | 0.07% | 404 |
|
|
2024
Q4 | $1.28M | Buy |
235,097
+63,804
| +37% | +$390K | 0.11% | 290 |
|
|
2024
Q3 | $1.24M | Sell |
171,293
-62,349
| -27% | -$571K | 0.11% | 322 |
|
|
2024
Q2 | $2.54M | Buy |
233,642
+90,252
| +63% | +$1.16M | 0.24% | 146 |
|
|
2024
Q1 | $2.69M | Sell |
143,390
-5,406
| -4% | -$125K | 0.25% | 137 |
|
|
2023
Q4 | $3.22M | Sell |
148,796
-32,829
| -18% | -$651K | 0.36% | 69 |
|
|
2023
Q3 | $3.74M | Buy |
181,625
+141,094
| +348% | +$4.07M | 0.47% | 42 |
|
|
2023
Q2 | $1.91M | Buy |
40,531
+14,211
| +54% | +$707K | 0.26% | 131 |
|
|
2023
Q1 | $1.1M | Buy |
26,320
+16,509
| +168% | +$710K | 0.15% | 238 |
|
|
2022
Q4 | $374K | Buy |
9,811
+152
| +2% | +$5.8K | 0.06% | 443 |
|
|
2022
Q3 | $378K | Sell |
9,659
-75,502
| -89% | -$2.92M | 0.06% | 518 |
|
|
2022
Q2 | $2.75M | Sell |
85,161
-29,455
| -26% | -$987K | 0.24% | 103 |
|
|
2022
Q1 | $3.79M | Buy |
114,616
+36,933
| +48% | +$1.39M | 0.33% | 54 |
|
|
2021
Q4 | $3.31M | Sell |
77,683
-11,217
| -13% | -$470K | 0.25% | 141 |
|
|
2021
Q3 | $3.94M | Sell |
88,900
-3,309
| -4% | -$152K | 0.28% | 161 |
|
|
2021
Q2 | $5.24M | Buy |
92,209
+46,706
| +103% | +$3.3M | 0.35% | 57 |
|
|
2021
Q1 | $3.41M | Sell |
45,503
-27,297
| -37% | -$2.24M | 0.24% | 165 |
|
|
2020
Q4 | $6.3M | Sell |
72,800
-5,770
| -7% | -$425K | 0.43% | 45 |
|
|
2020
Q3 | $4.8M | Sell |
78,570
-30,105
| -28% | -$1.53M | 0.32% | 133 |
|
|
2020
Q2 | $4.52M | Buy |
+108,675
| New | +$3.94M | 0.31% | 128 |
|
Other funds holding SAGE
IA
HNB